| Molecule | Cat. No. | Product Name | Art | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| IFN-beta | Human IFN-beta Protein, Fc Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $350.00 100ug | |||
| IFN-beta | AvitagAIDD‑Ready IFB-H82E4 | Biotinylated Human IFN-beta Protein, His,Avitag™ (MALS & SPR verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | ||
| IFN-beta | AvitagAIDD‑Ready IFB-M82E3 | Biotinylated Mouse IFN-beta Protein, His,Avitag™ (MALS & SPR verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Dazukibart | PF-06823859 | Phase 3 Clinical | Pfizer Inc | Dermatomyositis; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Muscular Diseases; Myositis; Polymyositis | Details |
| Peginterferon beta-1a (CinnaGen) | Phase 3 Clinical | Cinnagen | Multiple Sclerosis, Relapsing-Remitting | Details | |
| VSV-IFNbeta-NIS | Phase 2 Clinical | Vyriad | Angioimmunoblastic T-cell Lymphoma; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Endometrial Neoplasms; Histiocytoma; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Melanoma; Multiple Myeloma; Mycosis Fungoides; Myelodysplastic Syndromes; Sarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | Details | |
| VSV-hIFNbeta-NIS (University of Tennessee) | Phase 1 Clinical | The University Of Tennessee | Endometrial Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, T-Cell; Multiple Myeloma | Details | |
| MEM-288 | MEM-288 | Phase 1 Clinical | Memgen | Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | Details |
| SCD-153 | SCD-153 | Phase 1 Clinical | Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Johns Hopkins University, Sun Pharma Advanced Research Company Ltd | Alopecia Areata | Details |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Frühestes Markenname | Frühestes Genehmigungsland | Früheste Indikation | Früheste Genehmigungsgesellschaft | Früheste Genehmigungsdatum | Indikationen | Klinische Studie |
|---|---|---|---|---|---|---|---|---|---|---|
| Propagermanium | SK-818; SK-818C | Approved | Sanwa Kagaku Kenkyusho Co Ltd | Serocion | Japan | Hepatitis B | Sanwa Kagaku Kenkyusho Co Ltd | 1994-01-01 | Hepatitis B | Details |